Journal article icon

Journal article

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation

Abstract:

Background

Although several studies link high levels of IL-6 and soluble IL-6 receptor (sIL-6R) with asthma severity and decreased lung function, the role of IL-6 trans-signaling (IL-6TS) in asthma is unclear

Objective

To explore the association between epithelial IL-6TS pathway activation and molecular and clinical phenotypes in asthma.

Methods

An IL-6TS gene signature, obtained from air-liquid interface (ALI) cultures of human bronchial epithelial cells stimulated with IL-6 and sIL-6R, was used to stratify lung epithelium transcriptomic data (U-BIOPRED cohorts) by hierarchical clustering. IL-6TS-specific protein markers were used to stratify sputum biomarker data (Wessex cohort). Molecular phenotyping was based on transcriptional profiling of epithelial brushings, pathway analysis and immunohistochemical analysis of bronchial biopsies.

Results

Activation of IL-6TS in ALI cultures reduced epithelial integrity and induced a specific gene signature enriched in genes associated with airway remodeling. The IL-6TS signature identified a subset of IL-6TS High asthma patients with increased epithelial expression of IL-6TS inducible genes in absence of systemic inflammation. The IL-6TS High subset had an overrepresentation of frequent exacerbators, blood eosinophilia, and submucosal infiltration of T cells and macrophages. In bronchial brushings, TLR pathway genes were up-regulated while the expression of tight junction genes was reduced. Sputum sIL- 6R and IL-6 levels correlated with sputum markers of remodeling and innate immune activation, in particular YKL-40, MMP3, MIP-1b, IL-8 and IL-1β.

Conclusions

Local lung epithelial IL-6TS activation in absence of type 2 airway inflammation defines a novel subset of asthmatics and may drive airway inflammation and epithelial dysfunction in these patients.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1016/j.jaci.2018.05.026

Authors



Publisher:
Elsevier
Journal:
Journal of Allergy and Clinical Immunology More from this journal
Volume:
143
Issue:
2
Pages:
577-590
Publication date:
2018-06-11
Acceptance date:
2018-05-04
DOI:
EISSN:
1097-6825
ISSN:
0091-6749
Pmid:
29902480


Language:
English
Keywords:
Pubs id:
pubs:859099
UUID:
uuid:d4cca45f-dbcc-4b7e-9014-0a11ed5baf1a
Local pid:
pubs:859099
Source identifiers:
859099
Deposit date:
2018-06-25
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP